NPI registry status
Active
2026 NPPES data Pulmonary Disease Physician NPI 1184709297 MD
Verify on CMS → Reza Farhangfar, MD
Pulmonary Disease Physician in Wayne, New Jersey.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 9,647 in Pulmonary Disease Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
3K
Medicare Part D claims · 432 beneficiaries · Pulmonary Disease Physician avg: 1K
MIPS score
98.7/100
▲ 15 pts above national avg 83.5 · Exceptional
Industry payments
$157.73
10 payments · CMS Open Payments (Sunshine Act)
What the federal data shows
Reza Farhangfar, MD reported a CMS MIPS final score of 98.7/100 - above the 83.5 national average - and filed 3,487 Medicare Part D claims in 2024.
- 98.7/100
- MIPS score · +15 vs avg
- 3K
- Part D claims, 2024
- Likely
- board-certified (heuristic)
- ≥89th
- pct among measured MIPS (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Reza Farhangfar, MD
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1184709297), first enumerated 10/26/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 3,487 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 98.7/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$157.73 in reported industry payments (10 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1184709297 · Pulmonary Disease Physician
NPI-10 · ENUM-LEGACY · TAX-MID · MIPS-ELITE · RX-MID · BOOK-THIN · PHOTO-FINISH
- NPI-10 1184709297
- ENUM-LEGACY 2006
- TAX-MID 10K Pulmonary Disease
- MIPS-ELITE 98.7/100
- RX-MID 3,487
- BOOK-THIN 357 in New Jersey
- PHOTO-FINISH Edgardo Soto De La R… · ±0.1
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Sunya Ashraf · l…
Sunya Ashraf
98.5 MIPS pts
- Bahadir Baris · …
Bahadir Baris
98.6 MIPS pts
- Farhangfar · thi…
Farhangfar · this provider
98.7 MIPS pts
- Edgardo Soto De …
Edgardo Soto De La Rosa
98.8 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Reza Farhangfar, MD's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
99 ≥ 89th percentile 89% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Reza Farhangfar, MD sits
This provider among pulmonary disease physician peers
Across the 2,467 pulmonary disease physician providers who report both Medicare Part D prescribing and a MIPS quality score, Reza Farhangfar, MD writes more Part D claims than 88% of them and scores higher on MIPS quality than 90% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one pulmonary disease physician peer from a representative sample of 60; the gold marker is Reza Farhangfar, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Reza Farhangfar, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Reza Farhangfar, MD?
High performer (top quartile)Primary specialty
Pulmonary Disease Physician
Medicare Part D claims
3,487 133% vs specialty avg
MIPS final score
98.7/100 15.2 pts vs avg
Specialty distribution in New Jersey
How Pulmonary Disease Physician compares to other specialties among New Jersey providers
Medicare quality performance, MIPS
Reza Farhangfar, MD's 2023 MIPS final score plotted against the Pulmonary Disease Physician national average
- MIPS Final Score
- 98.7/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1184709297 |
|---|---|
| Specialty | Pulmonary Disease Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 10/26/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
98.6738
Final Score
Measured-score avg: 83.5
93.5705
Quality
100
Promoting Interoperability
Reporting: Alternative Payment Model
Hospital and facility affiliations
Facilities where Reza Farhangfar, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Valley Physician Services PC
Hoboken, NJ
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Reza Farhangfar, MD. Source: openpaymentsdata.cms.gov.
Total received
$158
Largest payer
GlaxoSmithKline, LLC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
3,487
Total Claims
$974K
Total Drug Cost
432
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 5,424.167
- Total Day Supply
- 154,131
- Generic Drug Cost
- $104K
- Opioid Claims
- 26 (0.7% rate)
- Antibiotic Claims
- 132
Patient Demographics
- Average Patient Age
- 76.4 years
- Avg HCC Risk Score
- 1.88
- Gender Split
- 63% female / 37% male
- Age Distribution
- <65: 34, 65-74: 157, 75-84: 145, 85+: 96
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Reza Farhangfar, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Albuterol Sulfate …
Albuterol Sulfate Hfa
373 claims
- Prednisone
Prednisone
278 claims
- Trelegy Ellipta
Trelegy Ellipta
202 claims
- Montelukast Sodium
Montelukast Sodium
166 claims
- Breo Ellipta
Breo Ellipta
154 claims
- Fluticasone Propio…
Fluticasone Propionate
150 claims
- Breztri Aerosphere 102
Breztri Aerosphere
102 claims
- Stiolto Respimat 99
Stiolto Respimat
99 claims
| Drug | Claims |
|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 373 |
| Prednisone | 278 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 202 |
| Montelukast Sodium | 166 |
| Breo Ellipta Fluticasone/Vilanterol | 154 |
| Fluticasone Propionate | 150 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 102 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 99 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 96 |
| Ipratropium Bromide | 85 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Pulmonary Disease Physician Overview
How Reza Farhangfar, MD fits within the Pulmonary Disease Physician landscape nationally.
9,647
Pulmonary Disease Physician Providers in US
53
States with Pulmonary Disease Physician
1,498
Avg Claims per Provider
Reza Farhangfar, MD's 3,487 claims are above the specialty average of 1,498.
Nationwide Pulmonary Disease Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Farhangfar, both outside New Jersey so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (98.7 here).
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Pulmonary Disease Physician Providers in New Jersey
Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as Farhangfar.
One of 357 Pulmonary Disease Physician providers enrolled in New Jersey, 5 are shown here.
Dr. Abdelrhman Abo-Zed
MD
Branchburg, NJ
Dr. Vincent Acampora
DO
Cherry Hill, NJ
Dr. Pankaja Achar
MD
Newark, NJ
Dr. William Adams
D.O.
Atlantic City, NJ
Dr. Abhishek Agarwal
MD
Marlton, NJ
Compare Pulmonary Disease Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Reza Farhangfar, MD's specialty? ▼
Reza Farhangfar, MD specializes in Pulmonary Disease Physician and practices in Wayne, New Jersey. Credentials: MD.
How much does Reza Farhangfar, MD prescribe under Medicare Part D? ▼
In 2024, Reza Farhangfar, MD wrote 3,487 Medicare Part D claims totaling $974K in drug costs for 432 beneficiaries.
What is Reza Farhangfar, MD's Medicare quality score? ▼
Reza Farhangfar, MD has a CMS MIPS Final Score of 98.7/100 (Quality: 93.6). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Reza Farhangfar, MD located? ▼
Reza Farhangfar, MD is located at 401 HAMBURG TPKE, Wayne, NJ, 07470. Phone: (973) 595-7456.
What is Reza Farhangfar, MD's NPI number? ▼
Reza Farhangfar, MD's National Provider Identifier (NPI) is 1184709297, issued on 10/26/2006.
Does Reza Farhangfar, MD prescribe opioids? ▼
Yes, Reza Farhangfar, MD had 26 opioid claims in 2024 with an opioid prescribing rate of 0.7%.
How many Pulmonary Disease Physician providers are there in the US? ▼
There are 9,647 Pulmonary Disease Physician providers across 53 states in the US. The average Pulmonary Disease Physician provider writes 1,498 Medicare Part D claims per year.
What drugs does Reza Farhangfar, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, Reza Farhangfar, MD's most frequently prescribed drugs include Albuterol Sulfate Hfa, Prednisone, Trelegy Ellipta. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Reza Farhangfar, MD accept Medicare? ▼
Reza Farhangfar, MD appears in CMS Medicare data with 3,487 Part D claims and 432 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Reza Farhangfar, MD's credentials? ▼
Reza Farhangfar, MD's NPI is 1184709297 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.